Visteon downgraded to Peer Perform from Outperform at Wolfe Research

Wolfe Research downgraded Visteon (VC) to Peer Perform from Outperform without a price target 2026 is expected to be a transition year with modest 2% organic revenue growth and limited EBITDA margin expansion, largely in line with Street estimates, the analyst tells investors in a research note. Upside appears constrained, with downside risk from the ongoing DRAM shortage, though valuation offers support and the long-term growth opportunity remains intact, the firm argues.